Cellular Biomedicine Group

136 articles about Cellular Biomedicine Group

• Cellular Biomedicine Group Completes Patient Treatment In Phase 2b Clinical Trial For Rejoin™ Therapy For Knee Osteoarthritis

  8/12/2014

• Cellular Biomedicine Group To Ring The NASDAQ Stock Market Closing Bell

  8/11/2014

• Cellular Biomedicine Group Announces Acquisition Of Immune Cell Therapy Technology And U.S. Patent

  8/4/2014

• Cellular Biomedicine Group Raises $10 Million In Private Placement

  7/16/2014

• Cellular Biomedicine Group Moves To NASDAQ Capital Market

  6/19/2014

• NeoStem, Inc. Out-Licenses China Rights For Cancer Immunotherapy To Cellular Biomedicine Group

  5/14/2014

• Cellular Biomedicine Group Announces Completion Of Patient Treatment For Phase I Clinical Trial For Liver Cancer

  12/16/2013

• Cellular Biomedicine Group Announces Adjournment Of Its Annual Shareholder Meeting

  11/11/2013

• Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for its Annual Shareholder Meeting

  11/8/2013

• Cellular Biomedicine Group Receives Approval for Phase IIb Clinical Trial of ReJoin&#0153 for Treatment of Knee Osteoarthritis (KOA)

  11/5/2013

• Cellular Biomedicine Group Offers Stromal Cell Purification Kits in China

  11/4/2013

• Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)

  11/1/2013

• Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License

  10/31/2013

• Cellular Biomedicine Group Calls for General Annual Shareholder Meeting on November 08, 2013

  10/25/2013

• Cellular Biomedicine GroupAppoints Three Independent Directors to the Board

  10/14/2013

• Cellular Biomedicine Group Announces Appointment of New CEO

  10/1/2013